Skip to main content
. 2017 Dec 15;8(69):114300–114313. doi: 10.18632/oncotarget.23259

Table 1. Oligonucleotide sequences of the primers and siRNAs.

Genes Oligonucleotide sequences Protocols
Primers
TNF-a Forward: 5′-CCGTCTCCTACCAGACCAAGG-3′
Reverse: 5′-CTGGAAGACCCCTCCCAGATAG-3′
IL-1b Forward: 5′-CTGATGGCCCTAAACAGATGAAG-3′
Reverse: 5′-GGTCGGAGATTCGTAGCAGCTGGAT-3′
IL-10 Forward: 5′-CATGCTGCTGGGCCTGAA-3′
Reverse: 5′-CGTCTCCTTGATCTGCTTGATG-3′
Sirt6 Forward: 5′-GCCCCGCTTCCGGCGGAAG-3′
Reverse: 5′-ATTGTTTTTATTGCATTGAGGAC-3′
Drosha Forward: 5′-TCCCTGCTGCCCAAGATTTC-3′ stage1: 95°C, 30 sec
Reverse: 5′-CAGGGCTTTGCTGCACCTTA-3′ stage2: 95°C, 5 sec
Sirt1 Forward: 5′-TGTGGTAGAGCTTGCATTGATCTT-3′ 55°C, 30 sec
Reverse: 5′-GGCCTGTTGCTCTCCTCATT-3′ 72°C, 35 sec
GAPDH Forward: 5′-AAGGTGAAGGTCGGAGTCA-3′ 40 cycles
Reverse: 5′-GGAAGATGGTGATGGGATTT-3′
siRNA
Sirt6 Sense: 5′-CCCUGGUCUCCAGCUUAAATT-3′
Anti-Sense: 5′-UUUAAGCUGGAGACCAGGGTT-3′
Sirt1 Sense: 5′-GATTATTGCCGGAAACAA-3′
Anti-Sense: 5′-TCCTTTCAGAACCACCAAA-3′
Drosha Sense: 5′-GGATTAGCAACCTATCGGA-3′
Anti-Sense: 5′-AAGGACCAAGTATTCAGCA-3′
GAPDH: Sense: 5′-GUAUGACAACAGCCUCAAGTT-3′
Anti-Sense: 5′-CUUGAGGCUGUUGUCAUACTT-3′